Sands Capital Ventures as of Sept. 30, 2023
Portfolio Holdings for Sands Capital Ventures
Sands Capital Ventures holds 23 positions in its portfolio as reported in the September 2023 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Nu Hldgs Ord Shs Cl A (NU) | 19.6 | $66M | 9.2M | 7.25 | |
| Uipath Cl A (PATH) | 15.5 | $53M | 3.1M | 17.11 | |
| Doordash Cl A (DASH) | 14.2 | $48M | 604k | 79.47 | |
| Snowflake Cl A (SNOW) | 9.8 | $33M | 216k | 152.77 | |
| Rayzebio | 7.9 | $27M | 1.2M | 22.20 | |
| Samsara Com Cl A (IOT) | 7.0 | $24M | 935k | 25.21 | |
| 10x Genomics Cl A Com (TXG) | 5.9 | $20M | 482k | 41.25 | |
| Klaviyo Class A Com (KVYO) | 4.8 | $16M | 469k | 34.50 | |
| Acrivon Therapeutics Common Stock (ACRV) | 4.7 | $16M | 1.7M | 9.56 | |
| Acumen Pharmaceuticals (ABOS) | 4.2 | $14M | 3.4M | 4.15 | |
| Olink Hldg Ab Sponsored Ads (OLK) | 3.1 | $10M | 706k | 14.75 | |
| Tarsus Pharmaceuticals (TARS) | 1.4 | $4.6M | 260k | 17.77 | |
| Taysha Gene Therapies Com Shs (TSHA) | 0.7 | $2.3M | 725k | 3.16 | |
| Spruce Biosciences (SPRB) | 0.5 | $1.8M | 787k | 2.26 | |
| 908 Devices (MASS) | 0.5 | $1.6M | 237k | 6.66 | |
| Candel Therapeutics (CADL) | 0.2 | $747k | 812k | 0.92 | |
| Crowdstrike Hldgs Cl A (CRWD) | 0.0 | $145k | 865.00 | 167.38 | |
| Coupang Cl A (CPNG) | 0.0 | $143k | 8.4k | 17.00 | |
| Toast Cl A (TOST) | 0.0 | $133k | 7.1k | 18.73 | |
| Datadog Cl A Com (DDOG) | 0.0 | $124k | 1.4k | 91.09 | |
| Absci Corp (ABSI) | 0.0 | $76k | 58k | 1.32 | |
| Confluent Class A Com (CFLT) | 0.0 | $34k | 1.2k | 29.61 | |
| Gitlab Class A Com (GTLB) | 0.0 | $30k | 658.00 | 45.22 |
